--- a
+++ b/clusters/9knumclustersv2/clust_152.txt
@@ -0,0 +1 @@
+Phase Ib: Received prior monoclonal antibody therapy other than bevacizumab within  weeks of study registration or who has not recovered (i.e., ? Grade  or at baseline) from adverse events of such agents administered more than  weeks earlier.